ArticleJournal of personalized medicine2025

Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.

Ugur Ozkerim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.